Mechanism Of Action And Application Of Nefiracetam

Nefiracetam is a hydrophobic derivative of piracetam and is synthesized from all Racetam compounds piracetam. Nefiracetam is mainly used to treat Alzheimer's disease. In addition to all mechanisms attributed to Nefiracetam, it is generally considered to be a substance that is responsible for the discovery of calcium channels in vivo, as well as for the indirect transfer of elicited signaling substances that act as partial agonists for the glycine binding site of the NDMA receptor.

Effect

Nefiracetam, a cognitive enhancer (prospermatotropic drug) of the Racetam family, is originally derived from the parent molecule piracetam but is most structurally similar to anisetan. Because Nefiracetam and anisetan are fat-soluble drugs. They are used to improve memory and cognitive disorders. Single-use Nefiracetam had no significant effect on the quality of memory. Nefiracetam can affect daily use memory formation for at least 7 days, repeating evidence in animal studies and showing the same effect in humans. Long-term use was also associated with a higher degree of neurogenesis that did not occur during a single reception.

The mechanism of action is Nefiracetam in two so-called ways. The first is to extend the openings of calcium channels (which bind to PKA and Gi/O proteins) that enhance receptor responses, regardless of synapses. The second pathway associated with PKC and CAMKII, which then completes the response due to cholinergic receptors (which are then followed by the release of the most excitatory neurotransmitters at the presynaptic level, such as nicotine). The former pathway (calcium channel) is important in the long term, while the latter pathway (PKC/CAMKII) has an effect on the enhancement of neural signaling and its transmission. Other minor ways could be partial agonists of NDMA receptors that bind glycine (which can enhance some level of glycine interaction, thereby weakening the interaction), and increased communication with the ligand acetylcholine, the musk acetylcholine receptor. Nefecittan is a cognitive enhancer that prolongs the action of calcium in activated neurons and improves memory function by increasing exposure to acetylcholine and glutamate at synapses.

Application

Nefiracetam is used to treat cerebrovascular disease. It can enhance the cognitive ability and prevent the damage of learning and memory by acting on the cerebral cortex. It does not have the characteristics of muscarinic receptor agonist and antagonist, nor does it inhibit the activity of acetylcholinase. Therefore, its anti-forgetting and memory enhancing effects occur through increasing the release of acetylcholine in the cerebral cortex.